Maternal congenital heart disease: Implications for the next generation
PLOS Medicine · 28.07.2026 · 23 (7) · e1005191
DOI: 10.1371/journal.pmed.1005191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Medicine, online erschienen am 28.07.2026. Verfasst von Elisabeth Leirgul und 1 weiteren Autor:innen. Beteiligte Einrichtung: Haukeland University Hospital, Bergen, Norway. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Pregnancy Complications, Cardiovascular. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in medical and surgical treatment of congenital heart disease (CHD) now allows most affected individuals to reach adulthood and parenthood. While maternal CHD is associated with pregnancy complications, emerging evidence suggests a possible increased risk of developmental challenges in offspring, particularly among children of mothers with severe CHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Haukeland University Hospital, Bergen, Norway.
- University of Bergen, Bergen, Norway.
ORCID-Profile: Elisabeth Leirgul, Gottfried Greve
Zitieren
APA
Leirgul, E., & Greve, G. (2026). Maternal congenital heart disease: Implications for the next generation. PLOS Medicine, 23(7), e1005191. https://doi.org/10.1371/journal.pmed.1005191
Vancouver
Leirgul E, Greve G. Maternal congenital heart disease: Implications for the next generation. PLOS Medicine. 2026;23(7):e1005191. doi:10.1371/journal.pmed.1005191
BibTeX
@article{Leirgul2026,
author = {Leirgul, Elisabeth and Greve, Gottfried},
title = {Maternal congenital heart disease: Implications for the next generation},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {7},
pages = {e1005191},
doi = {10.1371/journal.pmed.1005191}
}
EUVIMED